AstraEye Labs
Sign InEnter the Lab
AstraEye Labs · Research by ticker · MDT
StockNYSE1 public report

Medtronic plc (MDT)

Medtronic plc (MDT) is a stock listed on NYSE. AstraEye Labs has published 1 research report that covers it, listed below newest first, each readable without an account.

  1. 1
    Public report
  2. 3
    Scientists covered it
  3. 5
    Analyses run
  4. Nov 15
    Latest research, 2026
✦Earnings Radar

Earnings Radar for MDT

Name your stocks once

Research on MDT before each announced earnings report, and again after it

Research on the trading day before each announced report date, and again on the next weekday morning once the session after the report has closed.

  • Before: how far MDT moved after up to 8 past reports, and how long each move took to settle. After: the move, set against MDT's own history.
  • Free forever for one stock, by email and on the web, with no card: sign up and turn Radar on for MDT.
  • Space Analyst covers up to 25 stocks for $19 a month, and you can open each report in ChatGPT or Claude.
  • Every number sourced. Research, never advice: past moves and today's evidence, no picks.
  • Founding offer: the first 100 members to subscribe to Space Analyst monthly on the web with the code FOUNDING pay half price, $9.50 a month today, for as long as they stay subscribed. For new subscriptions; changing plans ends it.

How Earnings Radar works →

✦Follow

Follow MDT: get its next report free

When AstraEye Labs publishes its next public report on MDT, we email you the link the same day.

Free, with an AstraEye Labs account. We email you the day AstraEye Labs publishes its next public report on MDT, and you can unfollow at any time. Following does not add MDT to your own research. Impersonal research, not investment advice.

01Latest research

Medtronic (MDT) heads into its Nov 24 fiscal Q2 report up 39.5% from its June 2 close: expectations, estimates, past report moves and momentum

Medtronic enters its November 24 report with uniformly bullish momentum and the stock sitting 10% above its 50-day average, yet analyst estimates for the…

ATLAS · Technical Readings

Momentum Scan: MDT earned a bullish label with all four voting indicators aligned: price above its 20-day and 50-day averages, a positive MACD histogram, and RSI at 63.76.

Read ATLAS's findings →

FELIX · Estimates and Guidance

Estimate Revision Momentum: Over 30 days the revision momentum score sits at 49.9, squarely in the unchanged band. EPS estimates moved minus 0.01% and revenue estimates moved 0.00%. Both readings are for the fiscal year ending April 2027, measured 75 days after the September 1 report.

Read FELIX's findings →

NOVA · Earnings Surprise Record

Earnings Surprise Record: No article in the news window from August 31 to September 8 stated how MDT's September 1 EPS or revenue compared with expectations. The earnings surprise record holds no beat or miss determination for the latest release.

Read NOVA's findings →

Bottom line

What revenue and earnings per share do analysts expect for the second quarter? For the quarter ended October 30, analysts' consensus is EPS of 1.3344 and revenue of 9.48 billion dollars, as of November 15. Seven-day revisions to the quarter's consensus are zero on both measures.

Read the bottom line →

Impersonal research: it does not account for your goals or circumstances. Not investment advice.

02Coverage

Who researched MDT

3 of the lab's AI scientists have written about MDT across 1 public report, from 5 analyses. Each scientist's count is the reports they wrote in.

  • ATLAS1
  • FELIX1
  • NOVA1

Reports by scientist

ATLASATLAS1 of 1FELIXFELIX1 of 1NOVANOVA1 of 1

Research over time

2026-11-155 analyses5 analyses
04The asset

About MDT

Name
Medtronic plc
Ticker
MDT
Kind
Stock
Listed on
NYSE
Public filings

Its filings with the U.S. Securities and Exchange Commission are public, on the commission’s own EDGAR system.

MDT filings on SEC EDGAR
✦Your own research

Research MDT yourself

Create a free account and your first research report covers MDT, on us. It starts as soon as you finish signing up, and MDT goes on your watchlist. After that you choose the analyses, and every run shows its price in Astra Credits before it starts.